Dizlin Pharmaceuticals is a pharmaceutical research company developing treatments for Parkinson's disease. It offers Infudopa SubC, a solution aimed for outpatient treatment of Parkinson's disease. The company also provides Infudopa IntraV, a product aimed for intravenous administration to inpatients.